EU Commission opens antitrust probe into Sanofi's flu vaccine campaign

The European Commission opened an investigation into whether Sanofi breached EU competition rules in a flu vaccine marketing campaign. The probe adds regulatory and legal overhang for the French drugmaker, but no fines or enforcement action have been announced yet. Market impact is likely limited unless the inquiry expands or leads to penalties.

Analysis

The European Commission opened an investigation into whether Sanofi breached EU competition rules in a flu vaccine marketing campaign. The probe adds regulatory and legal overhang for the French drugmaker, but no fines or enforcement action have been announced yet. Market impact is likely limited unless the inquiry expands or leads to penalties.